Trump Announces IVF Cost Reduction Plans Without Mandates

President Donald Trump, who campaigned as the "father of IVF," pledged to make in vitro fertilization more accessible and affordable, even promising free IVF for all Americans. However, recent White House initiatives have fallen short of these promises, offering only modest cost reductions through discounted drugs from a single pharmaceutical company and encouraging—but not mandating—employers to provide IVF coverage. Critics note that these efforts lack substantive policy details, federal investment, or mandates, leaving many families unable to afford the full costs of IVF treatments, which include more than just medication. Experts emphasize that while the new employer benefit option could potentially cover infertility treatments, it remains unclear which treatments will be included or how plans will be regulated. The administration's approach has been characterized as insufficient, with skepticism about its ability to significantly increase IVF access or create a substantial increase in births due to IVF. Overall, the White House's IVF measures have been described as modest and largely symbolic, failing to fulfill Trump's campaign promises to make IVF universally affordable or free.